These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16876260)

  • 1. Intracellular 5-HT 2C-receptor dephosphorylation: a new target for treating drug addiction.
    Müller CP; Carey RJ
    Trends Pharmacol Sci; 2006 Sep; 27(9):455-8. PubMed ID: 16876260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN-5-HT2C coupling: a new target for treating drug addiction.
    Maillet JC; Zhang Y; Li X; Zhang X
    Prog Brain Res; 2008; 172():407-20. PubMed ID: 18772044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse.
    Ji SP; Zhang Y; Van Cleemput J; Jiang W; Liao M; Li L; Wan Q; Backstrom JR; Zhang X
    Nat Med; 2006 Mar; 12(3):324-9. PubMed ID: 16474401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.
    Berg KA; Harvey JA; Spampinato U; Clarke WP
    Prog Brain Res; 2008; 172():287-305. PubMed ID: 18772038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
    Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
    Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
    Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
    Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processes.
    Filip M; Spampinato U; McCreary AC; Przegaliński E
    Brain Res; 2012 Oct; 1476():132-53. PubMed ID: 22494568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
    Navailles S; Moison D; Ryczko D; Spampinato U
    J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cerebellar 5-HT(2C) receptors in pilocarpine-induced epilepsy in rats: therapeutic role of Bacopa monnieri extract.
    Krishnakumar A; Abraham PM; Paul J; Paulose CS
    J Neurol Sci; 2009 Sep; 284(1-2):124-8. PubMed ID: 19439326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
    Giorgetti M; Tecott LH
    Eur J Pharmacol; 2004 Mar; 488(1-3):1-9. PubMed ID: 15044029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior.
    Anastasio NC; Gilbertson SR; Bubar MJ; Agarkov A; Stutz SJ; Jeng Y; Bremer NM; Smith TD; Fox RG; Swinford SE; Seitz PK; Charendoff MN; Craft JW; Laezza FM; Watson CS; Briggs JM; Cunningham KA
    J Neurosci; 2013 Jan; 33(4):1615-30. PubMed ID: 23345234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice.
    Somerville EM; Horwood JM; Lee MD; Kennett GA; Clifton PG
    Eur J Neurosci; 2007 May; 25(10):3115-24. PubMed ID: 17561825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
    Aloyo VJ; Berg KA; Spampinato U; Clarke WP; Harvey JA
    Pharmacol Ther; 2009 Feb; 121(2):160-73. PubMed ID: 19109993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin 5-hydroxytryptamine2C receptor signaling in hypothalamic proopiomelanocortin neurons: role in energy homeostasis in females.
    Qiu J; Xue C; Bosch MA; Murphy JG; Fan W; Rønnekleiv OK; Kelly MJ
    Mol Pharmacol; 2007 Oct; 72(4):885-96. PubMed ID: 17622577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2C receptor agonists as an innovative approach for psychiatric disorders.
    Rosenzweig-Lipson S; Dunlop J; Marquis KL
    Drug News Perspect; 2007 Nov; 20(9):565-71. PubMed ID: 18176661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.
    Andrews MD; Green MP; Allerton CM; Batchelor DV; Blagg J; Brown AD; Gordon DW; McMurray G; Millns DJ; Nichols CL; Watson L
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5346-50. PubMed ID: 19692241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
    Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
    Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.